Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Nephrology | Gastroenterology | Family Medicine

Nephropathy Clinical Trials

A listing of Nephropathy medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 Last 

Alabama

Site Reference ID/Investigator# 105317
Birmingham Alabama 35211

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

California

Site Reference ID/Investigator# 99948
Alhambra California 91801

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96605
Azusa California 91702

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 99975
Chula Vista California 91911

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96591
Chula Vista California 91910

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105566
Downey California 90241

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

View More »

Site Reference ID/Investigator# 96597
La Mesa California 91942

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 99397
Los Angeles California 90036

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96596
Los Angeles California 90022

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96704
Mission Hills California 91345

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105199
Norwalk California 90650

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96702
Palm Springs California 92262

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 104900
Sacramento California 95825

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105316
San Diego California 92123

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96640
Santa Barbara California 93110

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Florida

Site Reference ID/Investigator# 99897
Kissimmee Florida 34741

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96623
Pembroke Pines Florida 33028

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96606
West Palm Beach Florida 33401

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Georgia

Site Reference ID/Investigator# 107999
Decatur Georgia 30030

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105177
Dunwoody Georgia 30338

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105155
Suwanee Georgia 30024

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Hawaii

Site Reference ID/Investigator# 96598
Honolulu Hawaii 96814

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Illinois

Site Reference ID/Investigator# 96588
Chicago Illinois 60616

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Louisiana

Ochsner Medical Center
New Orleans Louisiana 70121

A clinical research study of intravenous NAC and Placebo for the treatment of Nephropathy

Maryland

Site Reference ID/Investigator# 96610
Baltimore Maryland 21204

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96590
Rockville Maryland 20852

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Massachusetts

Site Reference ID/Investigator# 96637
Holyoke Massachusetts 01040

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 99946
Plymouth Massachusetts 02360

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Michigan

Site Reference ID/Investigator# 105176
Flint Michigan 48504

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96613
Flint Michigan 48503

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Nevada

Site Reference ID/Investigator# 104910
Reno Nevada 89511

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

New Jersey

Site Reference ID/Investigator# 103995
Eatontown New Jersey 07724

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

New York

The Rogosin Institute
New York New York 10021

Velcade Therapy For Severe IgA Nephropathy

View More »

Site Reference ID/Investigator# 96592
Albany New York 12206

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96604
New Hyde Park New York 11042

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 107215
New York New York 10001

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105235
New York New York 10128

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96603
Orchard Park New York 14220

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

North Carolina

Site Reference ID/Investigator# 96638
Charlotte North Carolina 28207

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 99898
Morehead City North Carolina 28557

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 100876
New Bern North Carolina 28562

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96602
Winston-Salem North Carolina 27103

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Pennsylvania

Site Reference ID/Investigator# 96607
Bethlehem Pennsylvania 18017

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105516
Pittsburgh Pennsylvania 15243

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

South Carolina

Site Reference ID/Investigator# 105175
Columbia South Carolina 29203

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 107197
Myrtle Beach South Carolina 29572

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96612
Orangeburg South Carolina 29118

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Texas

Site Reference ID/Investigator# 99896
Houston Texas 77004

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96608
McAllen Texas 78503

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 104913
San Antonio Texas 78224

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

First 1 2 Last